VERTEX PHARMACEUTICALS INC / MA Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for June 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 109.14 | 4,250 | 463,845 | 12,750 | |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 159.00 | 4,250 | 675,750 | 46,752 | 51 K to 46.8 K (-8.33 %) |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 109.14 | 4,250 | 463,845 | 51,002 | 46.8 K to 51 K (+9.09 %) |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Option Exercise | M | 109.14 | 4,250 | 463,845 | 12,750 | |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Sell | S | 160.00 | 4,250 | 680,000 | 46,699 | 50.9 K to 46.7 K (-8.34 %) |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, COO | Buy | M | 109.14 | 4,250 | 463,845 | 50,949 | 46.7 K to 50.9 K (+9.10 %) |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 83.36 | 106,500 | 8,877,840 | 0 | |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 160.00 | 140,211 | 22,433,760 | 157,049 | 297.3 K to 157 K (-47.17 %) |
Jun 26 2018 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 83.36 | 106,500 | 8,877,840 | 297,260 | 190.8 K to 297.3 K (+55.83 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 2,188 | 0 | 2,188 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | D | 0.00 | 2,188 | 0 | 5,925 | 8.1 K to 5.9 K (-26.97 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 1,801 | 0 | 8,113 | 6.3 K to 8.1 K (+28.53 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Sell | S | 152.05 | 875 | 133,044 | 4,879 | 5.8 K to 4.9 K (-15.21 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Bhatia Sangeeta N. | Director | Grant | A | 0.00 | 1,801 | 0 | 5,754 | 4 K to 5.8 K (+45.56 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 2,188 | 0 | 8,587 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | D | 0.00 | 2,188 | 0 | 13,011 | 15.2 K to 13 K (-14.40 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Grant | A | 0.00 | 1,801 | 0 | 15,199 | 13.4 K to 15.2 K (+13.44 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Garber Alan M | Director | Grant | A | 0.00 | 1,801 | 0 | 4,000 | 2.2 K to 4 K (+81.90 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,801 | 0 | 8,430 | 6.6 K to 8.4 K (+27.17 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Grant | A | 0.00 | 1,801 | 0 | 6,648 | 4.8 K to 6.6 K (+37.16 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Grant | A | 0.00 | 1,801 | 0 | 12,195 | 10.4 K to 12.2 K (+17.33 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 1,801 | 0 | 6,930 | 5.1 K to 6.9 K (+35.11 %) |